J-STAGE Home  >  Publications - Top  > Bibliographic Information

The Kurume Medical Journal
Vol. 42 (1995) No. 4 P 241-249



  • BURZYNSKI, SR. (1976). Antineoplastons; Biochemical defense against cancer. Physiol. Chem. Phys. 8, 275-279.
  • BURZYNSKI, SR. and HAI, T.T. (1985). Antineoplaston A-10. Drugs of the Future 10, 103-105.
  • BURZYNSKI, S.R., MOHABBAT, M.O. and LEE, S.S. (1986). Preclinical studies of Antineoplaston AS2-1 and Antineoplaston AS2-5. Drugs Exp. Clin. Res. (Suppl) 1, 25-28.
  • ERIGUCHI, N., HARA, H., YOSHIDA, H., NISHIDA, H., NAKAYAMA, T. et al. (1988). Chemopreventive effect of Antineoplaston A-10 on Urethaneinduced pulmonary neoplasm in mice. J. Jpn. Soc. Cancer Ther. 23, 1560-1565.
  • HENDRY, L.B., MULDOON, T.G., BURZYNSKI, S.R., COPLAND, J.A. and LERNER, A.F. (1987). Stereochemical modelling studies of the interaction of Antineoplaston A-10 with DNA. Drugs Exp. Clin. Res. (Suppl) 1, 77-81.
  • MULDOON, T.G., COPLAND, J.A. and HENDRY, L.B. (1988). Actions of Antineoplaston A-10 on the genesis and maintenance of specific subpopulations of rodent mammary tumor cells. Advances in Experimental and Clinical Chemotherapy 1, 15-18.
  • NISHIDA, H., YOSHIDA, H., ERIGUCHI, N., HOSHINO, K., KUBOTA, H. et al. (1991). Inhibitory effect of orally administered Antineoplaston A-10 on the growth curve of human breast cancer transplanted to athymic mice. J. Jpn. Soc. Cancer Ther. 26, 596-601.

Article Tools

Share this Article